Health Care Fraud Defense: Steps to Respond to Federal Investigations

The critical distinction turns on intent and knowledge. A billing error occurs when a claim contains inaccuracy but the submitter did not know and could not reasonably have known the claim was false. Health care fraud requires that the defendant either knew the claim was false or acted with reckless disregard for its truth. Courts evaluate this mental state by examining the defendant's access to accurate information, the training and compliance protocols in place, and whether similar errors appear systematically across multiple claims. A single coding mistake does not constitute fraud, but a pattern of identical miscodings after staff training suggests deliberate or reckless conduct. This is where disputes most frequently arise, because billing operations often involve multiple decision-makers and handoffs, making knowledge attribution complex.

Investigations typically begin with a qui tam relator (private whistleblower) filing under seal, or with a government agency audit triggered by billing anomalies. In New York, the Office of the Attorney General, the Department of Health, and federal prosecutors coordinate enforcement. Investigators request billing records, medical records, correspondence, employee training materials, and compliance policies. They conduct interviews and may execute search warrants. The investigation phase can last months or years before charges or civil complaints are filed. Early notification to counsel allows time to preserve documents, organize the factual record, and assess exposure before prosecutors or qui tam counsel move to litigation. Delay in responding to document requests or investigative inquiries can create inference problems later.

Under federal criminal law (18 U.S.C. § 1347), prosecutors must prove beyond a reasonable doubt that the defendant knowingly and willfully executed or attempted to execute a scheme to defraud a health care benefit program. The scheme must involve false or misleading representations made with the intent to obtain money or property. The government need not prove that the defendant obtained the money; the scheme itself is sufficient. For corporate defendants, prosecutors often charge the organization under respondeat superior theory, meaning the company can be liable for employee conduct if the employee acted within the scope of employment and intended to benefit the company. This creates significant exposure because the company's knowledge can be imputed from employees' actions, and compliance failures become evidence of corporate scienter. The False Claims Act, by contrast, requires only proof that a claim was false or misleading and was submitted with knowledge of its falsity; the burden is preponderance of the evidence in civil proceedings, and treble damages and penalties apply.

Federal health care fraud prosecutions are filed in the United States District Court for the Southern District of New York or the Eastern District of New York, depending on venue. State prosecutions occur in New York County Criminal Court or the county where the conduct occurred. Civil False Claims Act cases may be filed in federal district court. Procedurally, defendants in federal court must navigate grand jury proceedings, discovery obligations that can span thousands of documents, and potential parallel investigations by multiple agencies. A delay in responding to administrative subpoenas or grand jury subpoenas can result in adverse inference at trial. Courts in the SDNY have developed specialized procedures for health care fraud discovery, often requiring parties to meet and confer on document scope early to prevent discovery disputes from consuming litigation resources.

Organizations that maintain contemporaneous training records, written billing policies, auditing procedures, and evidence of employee discipline for violations build a factual foundation for arguing that any false claim resulted from individual misconduct rather than corporate policy or deliberate indifference. Prosecutors and qui tam counsel scrutinize whether compliance policies existed on paper only or were enforced in practice. Internal audit reports, compliance officer communications, and corrective action logs become central exhibits. If an organization discovered billing irregularities and reported them to payers or government agencies, that disclosure often supports a defense of lack of knowledge or reckless disregard. Conversely, evidence that compliance concerns were raised internally but ignored weakens the defense significantly. Documentation matters because it shapes the inference courts draw about corporate state of mind.

The False Claims Act allows private whistleblowers and the government to recover treble damages plus penalties for each false claim submitted. Health care fraud cases often involve parallel False Claims Act exposure alongside criminal charges. The civil standard of proof is lower than criminal, and civil discovery is broader. Defendants must prepare for both tracks simultaneously. Qui tam complaints are filed under seal and may remain confidential for months while the government investigates and decides whether to intervene. Once the seal is lifted, the case becomes public and can generate adverse publicity. Settlement negotiations in False Claims Act cases often occur before criminal charges are filed, creating a strategic window to resolve civil exposure and potentially influence the government's criminal posture.

Once an organization becomes aware of potential fraud allegations or receives investigative requests, it must implement a litigation hold on all potentially relevant documents, including billing records, medical records, emails, text messages, training materials, and compliance files. Failure to preserve documents can result in adverse inference sanctions. Organizations should also identify which employees had knowledge of or involvement in the conduct at issue and ensure those individuals are aware of the hold. Parallel to preservation, the organization should engage counsel to assess whether self-disclosure to the government or payers is strategically advisable. Health insurance fraud defense often hinges on whether the organization voluntarily revealed the problem or whether authorities discovered it independently. Early disclosure can reduce penalties but may accelerate litigation. This decision requires careful analysis of the strength of the underlying facts and the organization's risk tolerance.

Organizations must also assess eligibility for voluntary disclosure programs or settlement frameworks offered by the government. The Centers for Medicare and Medicaid Services and the Department of Justice maintain procedures for providers to self-report billing errors and settle liability without criminal prosecution. These programs require timely notice and cooperation. Waiting until an investigation is publicly known often forecloses access to these pathways. The defense strategy should therefore incorporate an early assessment of whether voluntary disclosure aligns with the organization's risk profile and whether the cost of litigation exceeds the likely settlement range under disclosure programs.